SIRT5-RAC2 Axis Drives Monocyte-to-Macrophage Differentiation to Promote Inflammatory Injury in Premature Ovarian Insufficiency

  • Adv Sci (Weinh). 2026 Mar;13(14):e18417. doi: 10.1002/advs.202518417.
Wenjing TanTai  1 Yaqi Li  1 Shengnan Liu  2 Minjuan Wu  1 Zhixiao Liu  1 Junfeng Jiang  1 Jingjing Chen  1 Xiaoding Xu  1 Li Li  1 Chaoqun Li  1 Fang Zhao  1 Ye Liu  1 Haitao Ni  1 Tengfei Zhang  3 Mingjuan Xu  2 Chaofeng Han  1
Affiliations
  • 1. Department of Histology and Embryology, National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, China.
  • 2. Department of Obstetrics and Gynecology of Changhai Hospital, Naval Medical University, Shanghai, China.
  • 3. Department of Gynaecology and Obstetrics of the People's Hospital of Zhuji, Wenzhou Medical University, Wenzhou, China.
Abstract

Premature ovarian insufficiency (POI) is a major cause of infertility and endocrine dysfunction, in which chronic inflammation plays a critical role. The homeostasis of tissue-resident macrophages and monocyte-differentiated macrophages from peripheral blood serves as a key mechanism of inflammation across organs, yet their phenotypic plasticity in ovarian pathologies, including POI, remains poorly understood. Here, we identify that SIRT5 deficiency decreases macrophage count by attenuating monocyte-macrophage differentiation. SIRT5 deficiency markedly attenuated follicular depletion and granulosa cell Apoptosis, coinciding with reduced M1 macrophage infiltration and cytokine expression in the POI model. Mechanistically, we uncovered RAC2 as a novel succinylation substrate of SIRT5. SIRT5 deficiency elevated RAC2 succinylation, promoting its proteasomal degradation and thereby impairing CSF1R-driven macrophage differentiation and M1 polarization. Pharmacological inhibition of SIRT5 recapitulated these protective effects, preserving follicular integrity and suppressing macrophage-mediated inflammation. Our findings identify the SIRT5-RAC2 axis as a key regulator of ovarian immune homeostasis and establish SIRT5 as a proof-of-concept therapeutic target for POI.

Keywords
RAC2; SIRT5; inflammation; macrophages; premature ovarian insufficiency.
Products